共 56 条
[1]
Pacak K(2007)Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005 Nat Clin Pract Endocrinol Metab 3 92-102
[2]
Eisenhofer G(2010)Molecular imaging of neuroendocrine tumors Semin Oncol 37 662-679
[3]
Ahlman H(2003)Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy J Clin Endocrinol Metab 88 5150-5157
[4]
Bornstein SR(2008)Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma J Nucl Med 49 1613-1619
[5]
Gimenez-Roqueplo AP(2011)68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours Mol Imaging Biol 13 769-775
[6]
Grossman AB(2012)Prospective evaluation of (68)Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study Eur Radiol 22 710-719
[7]
Carrasquillo JA(2010)6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression J Clin Endocrinol Metab 95 2800-2810
[8]
Chen CC(2001)[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas J Clin Endocrinol Metab 86 685-693
[9]
Mundschenk J(2008)123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation Clin Endocrinol 69 181-188
[10]
Unger N(2011)Comparison of [111In]-pentetreotide-SPECT and [18F]-FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities Clin Endocrinol 74 21-29